Therapeutic Equivalency Clinical Trial
Official title:
A Phase 1 Study of Liraglutide Injection and Victoza® in Healthy Chinese Subjects: An Open, Randomized, Single-Dose and Crossover Study
The study was designed as a single-site, randomized, open-label, crossover under fasted conditions. A single oral dose of 0.6 mg Liraglutide injection and Victoza® was given to the 32 healthy Chinese adult male volunteers.Blood samples were collected up to 72 h after administration.The primary pharmacokinetic endpoints were AUC0-t, AUC0-∞, and Cmax. Safety profile and immunogenicity data were collected from each subject.
The study was designed as a single-site, randomized, open-label, crossover under fasted conditions. A single oral dose of 0.6 mg Liraglutide injection and Victoza® was given to the 32 healthy Chinese adult male volunteers.Volunteers were randomized 1:1 at the beginning to receive a single 0.6 mg dose of Victoza® or Liraglutide injection by subcutaneous injection during the first period. Following 7 days washout period, all subjects received the alternate formulation during the second period. Blood samples were collected up to 72 h after administration.The primary pharmacokinetic endpoints were AUC0-t, AUC0-∞, and Cmax. Safety profile and immunogenicity data were collected from each subject. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04467346 -
Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules
|
Phase 1 | |
Completed |
NCT00807118 -
Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect
|
Phase 1 | |
Withdrawn |
NCT01405170 -
A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions
|
Phase 1 | |
Completed |
NCT04885660 -
Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT05786339 -
Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00709189 -
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
|
Phase 1 | |
Completed |
NCT00685165 -
Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets
|
Phase 1 | |
Completed |
NCT00658541 -
Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets
|
Phase 1 | |
Completed |
NCT00997789 -
Bioequivalence of Rebamipide in Korean
|
N/A | |
Completed |
NCT00684762 -
Fasted Bioavailability Study of Cilostazol Tablets, 100 mg
|
Phase 1 | |
Recruiting |
NCT04814589 -
Bioequivalence of Ezetimibe Tablets in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03631316 -
Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir
|
N/A | |
Recruiting |
NCT04438720 -
Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01359163 -
A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects
|
Phase 1 | |
Completed |
NCT00650221 -
Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects
|
Phase 1 | |
Completed |
NCT00648544 -
Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects
|
Phase 1 | |
Withdrawn |
NCT01405131 -
A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets
|
Phase 1 | |
Withdrawn |
NCT01405157 -
A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT05282940 -
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
|
Phase 1 | |
Completed |
NCT06050343 -
Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method
|
N/A |